Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inga Zerr

Showing results (341-350 of 358) with videos related to

Pageof 36
Sort By:
Neurology|June 8, 2019
Age at onset in genetic prion disease and the design of preventive clinical trialsEric Vallabh Minikel, Sonia M Vallabh, Margaret C Orseth, et al.
Plos Medicine|August 21, 2020
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control studyHana Saddiki, Aurore Fayosse, Emmanuel Cognat, et al.
The Lancet. Neurology|January 14, 2014
Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trialStéphane Haïk, Gabriella Marcon, Alain Mallet, et al.
Prion|May 26, 2016
The Priority position paper: Protecting Europe's food chain from prionsJesús R Requena, Krister Kristensson, Carsten Korth, et al.
European Journal of Neurology|May 7, 2022
Concordance of cerebrospinal fluid real-time quaking-induced conversion across the European Creutzfeldt-Jakob Disease Surveillance NetworkNeil McKenzie, Gabriele Piconi, Audrey Culeux, et al.
Brain : a Journal of Neurology|January 27, 2025
Multiomic analyses direct hypotheses for Creutzfeldt-Jakob disease risk genesFahri Küçükali, Elizabeth Hill, Tijs Watzeels, et al.
Plos One|July 30, 2024
Genome wide association study of clinical duration and age at onset of sporadic CJDHolger Hummerich, Helen Speedy, Tracy Campbell, et al.
Journal of Neurology|February 14, 2024
The comorbidity profiles and medication issues of patients with multiple system atrophy: a systematic cross-sectional analysisLan Ye, Stephan Greten, Florian Wegner, et al.
Acta Neuropathologica|July 9, 2024
Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseasesFeizhi Song, Valerija Kovac, Behnam Mohammadi, et al.
Science Translational Medicine|January 14, 2026
Brain-derived tau for monitoring brain injury in acute ischemic strokeNaomi Vlegels, Nicoló L Knuth, Konstantin A Steiner, et al.
Pageof 36

Showing results (341-350 of 358) with videos related to

Sort By:
Pageof 36
Neurology|June 8, 2019
Age at onset in genetic prion disease and the design of preventive clinical trialsEric Vallabh Minikel, Sonia M Vallabh, Margaret C Orseth, et al.
Plos Medicine|August 21, 2020
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control studyHana Saddiki, Aurore Fayosse, Emmanuel Cognat, et al.
The Lancet. Neurology|January 14, 2014
Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trialStéphane Haïk, Gabriella Marcon, Alain Mallet, et al.
Prion|May 26, 2016
The Priority position paper: Protecting Europe's food chain from prionsJesús R Requena, Krister Kristensson, Carsten Korth, et al.
European Journal of Neurology|May 7, 2022
Concordance of cerebrospinal fluid real-time quaking-induced conversion across the European Creutzfeldt-Jakob Disease Surveillance NetworkNeil McKenzie, Gabriele Piconi, Audrey Culeux, et al.
Brain : a Journal of Neurology|January 27, 2025
Multiomic analyses direct hypotheses for Creutzfeldt-Jakob disease risk genesFahri Küçükali, Elizabeth Hill, Tijs Watzeels, et al.
Plos One|July 30, 2024
Genome wide association study of clinical duration and age at onset of sporadic CJDHolger Hummerich, Helen Speedy, Tracy Campbell, et al.
Journal of Neurology|February 14, 2024
The comorbidity profiles and medication issues of patients with multiple system atrophy: a systematic cross-sectional analysisLan Ye, Stephan Greten, Florian Wegner, et al.
Acta Neuropathologica|July 9, 2024
Cleavage site-directed antibodies reveal the prion protein in humans is shed by ADAM10 at Y226 and associates with misfolded protein deposits in neurodegenerative diseasesFeizhi Song, Valerija Kovac, Behnam Mohammadi, et al.
Science Translational Medicine|January 14, 2026
Brain-derived tau for monitoring brain injury in acute ischemic strokeNaomi Vlegels, Nicoló L Knuth, Konstantin A Steiner, et al.
Pageof 36